Health Canada
- Status: approved
🇨🇦 Montelukast (High FeNO group) in Canada
Montelukast (High FeNO group) (Montelukast (High FeNO group)) regulatory status in Canada.
Marketing authorisation
Montelukast (High FeNO group) in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Respiratory approved in Canada
Frequently asked questions
Is Montelukast (High FeNO group) approved in Canada?
Yes. Health Canada has authorised it.
Who is the marketing authorisation holder for Montelukast (High FeNO group) in Canada?
Hull University Teaching Hospitals NHS Trust is the originator. The local marketing authorisation holder may differ — check the official source linked above.